Based on the data in Figs. 1–3, we reasoned that M-MDSCs are bound to osteoblasts in the bone marrow of tumor hosts, and the binding becomes disengaged upon PTH1R activation by tumor-derived PTHrP. Here, PTH1R is linked to neoplasm.